LONDON (Reuters) - Women with mutations in a gene called PALB2 have a one in three chance of developing breast cancer by age 70, according to research that suggests PALB2 is almost as important a risk ...

New research found that the risk of developing breast cancer increased in women who had mutations of a gene related to BRCA2, the PALB2 gene. New research found that the risk of developing breast ...

At the American Society of Clinical Oncology (ASCO) annual meeting, updated data on the use of olaparib (Lynparza) in patients with metastatic breast cancer (MBC) with somatic BRCA1/2 and germline ...

Sisters Mary Pat and Susan O'Hern have battled breast cancer multiple times over two decades. A shared PALB2 gene mutation increased their risk for the disease, impacting other family members as well.

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk Patients in the mutation-positive group had a median OS ...

The SHARON trial combines chemotherapy, vitamins, and stem cells to treat advanced pancreatic cancer with BRCA or PALB2 mutations, showing promising early results. This precision medicine approach ...